ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Consumer Discretionary / PASW / news
TLF (35) BIRD (34) NCI (33) BRIA (49) ⌘ Pro Terminal →

Why PASW Stock dropped -8.59% Today — RQD Quant Desk Flash

$4.68 -8.59% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $4.60

Ping An Biomedical Co. Ltd. (Class A) (PASW) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $16.0M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PASW Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PASW stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Ping An Biomedical Co. Ltd. (Class A) (NASDAQ: PASW) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $4.68 (-8.59% 1D, market cap $16.0M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 3/20. Across 1009 tracked Consumer Discretionary issuers, PASW ranks #834 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PASW compare to TLF and BIRD in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Apparel), PASW carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 2.8%, and ROIC of —. By comparison, TLF (Tandy Leather Factory Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -2.1%, cap $18.0M) and BIRD (Smartbird Inc. (Class A)) posts a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $23.0M). Among the 5-stock peer group, NCI leads on earnings multiple (153.8x) while NCI leads on capital efficiency (2.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PASW?
▼

Per PASW's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0001897532), Ping An Biomedical Co. Ltd. (Class A) generated $4.8M in revenue, -$1.8M in net income, and -$902.9K in free cash flow against $9.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $4.60 (-1.74%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510033
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Cash (10)Whales (6)SEC (8)Macro (6)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-11.3% Base Target
$31 Bull$4 Base$3 Bear
📬 FREE PASW RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PASW)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (33/100 Composite)
🔍 WHY PASW SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+10/20 pts (30% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 2.8% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (24% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 1/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
41
Grade D$5.04-0.8% Next Q
Q2 (-2Q)
38
Grade E$5.00-2.4% Next Q
Q3 (-1Q)
36
Grade E$4.88-4.1% Next Q
Current
33
Grade E$4.68-8.9% Hist 90D α
Trajectory: D (41) → E (33)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a PASW Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While PASW currently carries a cautious 33/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($5.14) and Max Pain ($4.91) forces dealer call-delta covering toward $30.74.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PASW• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PASW Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
YES 33%NO 67%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why PASW Stock dropped -8.59% Today — RQD Quant Desk Flash

Ping An Biomedical Co. Ltd. (Class A) (PASW) dropped -8.59% to $4.68, trading at 6% of its 52-week range ($3.07 – $29.28). Stretched risk/reward at current multiples (2.8% gross margin) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 6% of its 52-week range ($3.07 – $29.28) with RSI-14 at 51.7 (NEUTRAL RANGE).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $4.68 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 2.8% gross margin and $0 annual free cash flow.
Live PASW Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PASW)

  • ✓Walkthrough of PASW's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
PASW // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -27.33%📐 HORIZONTAL RANGE
2026-11-03O $5.00H $5.12L $4.68C $4.68VOL 62.5K
RES: $10.89SUP: $2.81SMA50: $5.14SMA200: $6.09
$28.87$21.88$14.88$7.89$0.90RES $10.89SUP $2.81$4.682026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PASW Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PASW Butterfly Map → + Track PASW →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on PASW today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PASW. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PASW today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PASW)

Consumer Discretionary Rank #834 of 1009 ⚔️ TLF vs PASW Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (PASW vs. TLF, BIRD, NCI, BRIA)

Industry: Apparel (27 Tracked Issuers)

Across 1009 tracked Consumer Discretionary securities in the Roarable RQD universe, Ping An Biomedical Co. Ltd. (Class A) (PASW) ranks #834 by composite RQD confidence (33/100, grade E) and #893 by equity capitalization ($16.0M). Within this direct 5-issuer industry benchmark cohort, NCI leads on earnings valuation at 153.8x trailing P/E, while NCI leads on capital efficiency and profitability with 2.6% ROIC and 36.9% gross margin. BRIA currently holds the highest overall quantitative score in the immediate peer group at 49/100 (D) compared with PASW at 33/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
PASW ACTIVE
Ping An Biomedical Co. Ltd. (Class A)
E 33/100 — 2.8% — -8.59% $16.0M Benchmark Subject
TLF
Tandy Leather Factory Inc.
D- 35/100 — 57.0% -2.1% +1.36% $18.0M /tlf-vs-pasw →
BIRD
Smartbird Inc. (Class A)
E 34/100 — 41.0% -35.0% -16.92% $23.0M /bird-vs-pasw →
NCI
Neo-Concept International Group Holdings Limited (Class A)
E 33/100 153.8x 36.9% 2.6% -2.86% $6.4M /nci-vs-pasw →
BRIA
BrilliA Inc (Class A)
D 49/100 — — — +2.17% $42.3M /bria-vs-pasw →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-09-30 • CIK 0001897532 ↗

In its most recent audited fiscal period (FY2025, filed 2025-09-30), Ping An Biomedical Co. Ltd. (Class A) (PASW) reported GAAP revenue of $4.8M , GAAP net income of -$1.8M, operating cash flow of -$902.9K, and free cash flow of -$902.9K . On the balance sheet, PASW closed FY2025 with $9.6M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-09-30 $4.8M -$1.8M -$902.9K -$902.9K $9.6M —

3. PASW Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PASW stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Ping An Biomedical Co. Ltd. (Class A) (NASDAQ: PASW) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $4.68 (-8.59% 1D, market cap $16.0M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 3/20. Across 1009 tracked Consumer Discretionary issuers, PASW ranks #834 in composite RQD confidence.

How does PASW compare to TLF and BIRD in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Apparel), PASW carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 2.8%, and ROIC of —. By comparison, TLF (Tandy Leather Factory Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -2.1%, cap $18.0M) and BIRD (Smartbird Inc. (Class A)) posts a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $23.0M). Among the 5-stock peer group, NCI leads on earnings multiple (153.8x) while NCI leads on capital efficiency (2.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PASW?

Per PASW's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0001897532), Ping An Biomedical Co. Ltd. (Class A) generated $4.8M in revenue, -$1.8M in net income, and -$902.9K in free cash flow against $9.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PASW trading relative to its 50-day, 200-day, and 52-week technical levels?

PASW last traded at $4.68 (-8.59% on volume of 71,682 shares), positioning the stock -8.95% below its 50-day simple moving average ($5.14) and -23.15% below its 200-day simple moving average ($6.09). Across its 52-week range of $3.07 to $29.28, PASW sits at the 6.1% percentile with a 14-day RSI of 51.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.10 to $5.26).

Direct Sub-Reports: PASW RQD Cockpit PASW 12M Forecast PASW Earnings & Move PASW Dividends & DRIP PASW Insiders & 13F PASW Whale Options PASW Profit Sankey PASW News & Why
ROARABLE RATING BRIEF • RQD 33/100 (E) ✓ SEC XBRL & RQD VERIFIED

PASW — Ping An Biomedical Co. Ltd. (Class A): What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-09-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Ping An Biomedical Co. Ltd. (Class A) (PASW) earns a live Roarable RQD composite score of 33/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $4.68 (-8.59% 1D, market capitalization $16.0M).

  • Fundamental Cash Engine (10/20): Anchored by return on invested capital (ROIC) of —, gross margin of 2.8%, operating margin of -43.1%, and free cash flow yield of -5.77%.
  • Whale 13F & Options Flow (6/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (6/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 1/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

. Ltd. (Class A) is a NASDAQ-listed company in the Consumer Discretionary sector and Apparel industry. The profile lists a market capitalization of $0.0B. — for detailed product lines, customer base, or revenue mix. The company reported revenue of $4.8M for FY 2025.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-09-30), Ping An Biomedical Co. Ltd. (Class A) (PASW) reported $4.8M in annual revenue and -$1.8M in GAAP net income. Operating cash flow reached -$902.9K and free cash flow totaled -$902.9K, backed by $9.6M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 33/100): Established market leader in Consumer Discretionary with deep daily trading liquidity. Free cash flow yield of -5.77% and institutional whale pillar of 6/20. With Fundamental Cash Engine at 10/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $3.07 – $29.28 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -43.1% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Sector is Consumer Discretionary and industry is Apparel, but no upstream or downstream dependencies, sector correlations, or second-order bottlenecks are available in the source data. — for specific ripple effects.

  • Key Question #1: Can PASW sustain or expand its -43.1% operating margin and — ROIC against Apparel peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $4.8M and free cash flow of -$902.9K, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is PASW's equity valuation to Consumer Discretionary capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

PASW Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Ping An Biomedical Co. Ltd. (Class A) (PASW) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to PASW Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

PASW Bull vs. Bear Conversation Board — What's Your Call at $4.68?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PASW 🐻 33% BEARISH CONVICTION
1. Pick Your Side on PASW:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH 🎯 Target: $6.14 (+19.9%)
📌 Pinned Debate

Shareholders approved a major share consolidation and capital increase, and the stock recently gained 2.66% to $5.01 as it pressed towa

Long PASW at $5.12 targeting $6.14. Shareholders approved a major share consolidation and capital increase, and the stock recently gained 2.66% to $5.01 as it pressed toward an upper range.. Institutional whale score is 6/20 and the risk/reward vs. the $3.07 52-week low is skewed heavily in favor of bulls.

VolSurface_Trader 🐂 BULL

@RedlineAuditor Shorting a 6/20 institutional whale-flow stock at $5.12 is dangerous when funds are rotating into Consumer Discretionary.

RE RedlineAuditor RQD DEBATE OPENER • Accounting Quality Watch 🐻 BEARISH 🎯 Target: $4.04 (-21.1%)
Spot @ $5.12

The RQD score of 32 (grade E) reflects a 0% ROIC, -5.77% FCF yield, and a Piotroski F-Score of 1/9, with operating margin at -43.1%.

Fading this rally in PASW at $5.12. The RQD score of 32 (grade E) reflects a 0% ROIC, -5.77% FCF yield, and a Piotroski F-Score of 1/9, with operating margin at -43.1%.. With a beta of 1.0 and the stock sitting at $5.12 (52-wk range $3.07–$29.28), the easy multiple expansion is already priced in.

LIVE TAPE